89. Neoadjuvant Therapy versus Upfront Surgery in Patients with Node Negative Esophageal Cancer
The Journal of Thoracic and Cardiovascular Surgery · 2026-05 · 171 (4) · S58-S59
DOI: 10.1016/j.jtcvs.2026.03.152 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Thoracic and Cardiovascular Surgery, 2026-05. Verfasst von Jericho Hallare und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Hallare, J., Pohlman, A., Coughlin, J. M., Raad, W., Lubawski, J., & Abdelsattar, Z. M. (2026). 89. Neoadjuvant Therapy versus Upfront Surgery in Patients with Node Negative Esophageal Cancer. The Journal of Thoracic and Cardiovascular Surgery, 171(4), S58-S59. https://doi.org/10.1016/j.jtcvs.2026.03.152
Vancouver
Hallare J, Pohlman A, Coughlin JM, Raad W, Lubawski J, Abdelsattar ZM. 89. Neoadjuvant Therapy versus Upfront Surgery in Patients with Node Negative Esophageal Cancer. The Journal of Thoracic and Cardiovascular Surgery. 2026;171(4):S58-S59. doi:10.1016/j.jtcvs.2026.03.152
BibTeX
@article{Hallare2026,
author = {Hallare, Jericho and Pohlman, Alexander and Coughlin, Julia M. and Raad, Wissam and Lubawski, James and Abdelsattar, Zaid M.},
title = {89. Neoadjuvant Therapy versus Upfront Surgery in Patients with Node Negative Esophageal Cancer},
journal = {The Journal of Thoracic and Cardiovascular Surgery},
year = {2026},
volume = {171},
number = {4},
pages = {S58--S59},
doi = {10.1016/j.jtcvs.2026.03.152}
}
EUVIMED